Efficacy of Two Vaginal Solutions in Preoperative Use

• Status: Unknown status
• Trial end date: 2019-03-01
• Target enrollment: 0
• Participant gender: Female

Summary

This study is necessary in order to provide proof the effectiveness of Chlorhexidine gluconate and its safety.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: HaEmek Medical Center, Israel
• Treatments: Chlorhexidine; Chlorhexidine gluconate; Iodine; Povidone; Povidone-Iodine

Criteria

Inclusion Criteria:

1. Patients over the age of 18

2. Candidates for surgery (TOT- Trans Obturator Tape, cystoscopy, the introduction / removal of the stent the ureter, ureteroscopy), local or general anesthesia.

Exclusion Criteria:

1. A pregnant woman or post-partum.

2. A woman with known sensitivity to iodine, povidon or chlorhexidine.

3. Previous pelvic surgeries within three months from the surgery planned.

4. Patients taking antibiotics within one month from the surgery planned.

5. Immunological failure patients.

6. Patient unwilling to participate in the study.

7. Patients who require the appointment of a guardian condition

8. Women assigned to undergo a regular cystoscopy (no further action).